MarketInOut Stock Screener Log In | Sign Up

Myriad Genetics Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Myriad Genetics Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization634.16 mln
Float88.60 mln
Earnings Date11/04/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.63
Highly reliable

1-Year Forecast

4.49
Downside risk

Relative Strength

100 / 100
Top performer

Debt / Equity

0.69
Moderate leverage

Pre-Tax Margin

-14%
Loss-making

Business Description

Myriad Genetics is a Salt Lake City-based company founded in 1991 that creates DNA and molecular tests to help doctors detect, diagnose, and manage a wide range of health conditions. Its tests cover areas such as hereditary cancer risk, breast and prostate cancer progression, prenatal screening, mental health medication guidance, and chromosomal disorders in unborn babies. The company works with leading research institutions and healthcare organizations worldwide, including the MD Anderson Cancer Center, Mayo Clinic, and Institut Curie, to continuously advance its testing capabilities.

Key Fundamentals

EPS-1.18
ROE-31.80
RPS8.61
ROIC-18.94
ROA-16.44
Interest Cover-6.01
EBITDA, mln-46.30
EV / EBITDA-14.95
EV / EBIT-7.26
Revenue, mln807
EV / Revenue0.86

Quote Details

Last 6.35
Change -0.32 (-4.8%)
Open 6.51
Volume 1,500,611
Turnover 9,528,880
Average Volume 3,067,878

Financial Ratios

Pre-Tax Profit Margin-14
Leverage Ratio2.10
Current Ratio2.21
Price / Book1.98
Price / Tangible Book5.11
Price / Cash Flow81.63
Debt / Equity0.69
Price / Sales0.73
PEG Ratio1.24

Financial Strength

Altman Z-Score-0.48
Piotroski F-Score 5 / 9
Beneish M-Score-3.63
1-Year Target Price4.49
Short Ratio4.59
Short % of Float9.93

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.11% 93 / 100   
1 Month 56.4% 99 / 100   
2 Months 16.51% 91 / 100   
6 Months 32.29% 93 / 100   
1 Year -19.72% 30 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog